Table: Sumitomo Pharma -2022/23 parent results

Sumitomo Pharma

15/05/2023 05:00

May 15 (Reuters)- 
          Sumitomo Pharma Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to       NEXT   
               Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                  LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales           231.76          302.39                                
               (-23.4 pct)      (-3.7 pct)                              
  Operating        54.94          111.18                                
               (-50.6 pct)      (-12.9 pct)                             
  Recurring       104.77          140.87                                
               (-25.6 pct)      (+3.6 pct)                              
  Net          loss 182.96         58.72                                
                                (-49.6 pct)                             
  EPS        loss 460.52 yen    147.81 yen                              
  Ann Div       21.00 yen        28.00 yen         NIL                  
  -Q2 Div       14.00 yen        14.00 yen         NIL                  
  -Q4 Div        7.00 yen        14.00 yen         NIL                  
  
  NOTE - Sumitomo Pharma Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4506.T